Exjade (deferasirox) is an oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta-thalassemia and other chronic anemias.

  • Fatal GI hemorrhages, especially in elderly patients who had advanced hematologic malignancies and/or low platelet counts, have been reported. Non-fatal upper GI irritation, ulceration and hemorrhage have been reported in patients, including children and adolescents
  • It is not recommended to use Exjade in combination with drugs that have ulcerogenic or hemorrhagic potential, such as non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, oral bisphosphonates, or anticoagulants.
  • Exjade may cause: renal impairment, including failure; hepatic impairment, including failure; gastrointestinal hemorrhage

Free Consultation | Dangerous Drug Attorneys

Friedman Law Offices, P.C., L.L.O. is here to help. To schedule a free consultation with our dangerous drug attorneys, contact us online, or by calling 866-458-5468 or toll free 888-419-6876.